Activated Protein C Enhances Human Keratinocyte Barrier Integrity via Sequential Activation of Epidermal Growth Factor Receptor and Tie2

被引:40
|
作者
Xue, Meilang [1 ]
Chow, Shu-Oi [1 ]
Dervish, Suat [1 ]
Chan, Yee-Ka Agnes [1 ]
Julovi, Sohel M. [1 ]
Jackson, Christopher J. [1 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia
基金
英国医学研究理事会;
关键词
CELL-CELL CONTACTS; SIGNALING PATHWAYS; TIGHT JUNCTIONS; ANGIOPOIETIN-1; SKIN; EXPRESSION; SURVIVAL; TRANSACTIVATION; DIFFERENTIATION; PSORIASIS;
D O I
10.1074/jbc.M110.181388
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Keratinocytes play a critical role in maintaining epidermal barrier function. Activated protein C (APC), a natural anticoagulant with anti-inflammatory and endothelial barrier protective properties, significantly increased the barrier impedance of keratinocyte monolayers, measured by electric cell substrate impedance sensing and FITC-dextran flux. In response to APC, Tie2, a tyrosine kinase receptor, was rapidly activated within 30 min, and relocated to cell-cell contacts. APC also increased junction proteins zona occludens, claudin-1 and VE-cadherin. Inhibition of Tie2 by its peptide inhibitor or small interfering RNA abolished the barrier protective effect of APC. Interestingly, APC did not activate Tie2 through its major ligand, angiopoietin-1, but instead acted by binding to endothelial protein C receptor, cleaving protease-activated receptor-1 and transactivating EGF receptor. Furthermore, when activation of Akt, but not ERK, was inhibited, the barrier protective effect of APC on keratinocytes was abolished. Thus, APC activates Tie2, via a mechanism requiring, in sequential order, the receptors, endothelial protein C receptor, protease-activated receptor-1, and EGF receptor, which selectively enhances the PI3K/Akt signaling to enhance junctional complexes and reduce keratinocyte permeability.
引用
收藏
页码:6742 / 6750
页数:9
相关论文
共 50 条
  • [41] Insufficiency of Pro-heparin-binding Epidermal Growth Factor-like Growth Factor Shedding Enhances Hypoxic Cell Death in H9c2 Cardiomyoblasts via the Activation of Caspase-3 and c-Jun N-terminal Kinase
    Uetani, Teruyoshi
    Nakayama, Hironao
    Okayama, Hideki
    Okura, Takafumi
    Higaki, Jitsuo
    Inoue, Hirofumi
    Higashiyama, Shigeki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18) : 12399 - 12409
  • [42] Phosphorylation of epidermal growth factor receptor at serine 1047 by MAP kinase-activated protein kinase-2 in cultured lung epithelial cells treated with flagellin
    Noguchi, Nobuhiro
    Kondo, Yutaka
    Maeda, Noriko
    Higa-Nakamine, Sayomi
    Toku, Seikichi
    Maruyama, Junichi
    Isohama, Yoichiro
    Kukita, Ichiro
    Sugahara, Kazuhiro
    Yamamoto, Hideyuki
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2013, 529 (02) : 75 - 85
  • [43] Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2)
    Amina, Belhadj
    Lynda, Addou Klouche
    Sonia, Seddiki
    Adel, Belhadj
    Jelloul, Benammar H.
    Miloud, Medjamia
    Tewfik, Sahraoui
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (02) : 254 - 260
  • [44] A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer
    Chia, Stephen K.
    Ellard, Susan L.
    Mates, Mihaela
    Welch, Stephen
    Mihalcioiu, Catalin
    Miller, Wilson H., Jr.
    Gelmon, Karen
    Lohrisch, Caroline
    Kumar, Vikaash
    Taylor, Sara
    Hagerman, Linda
    Goodwin, Rachel
    Wang, Tao
    Sakashita, Shingo
    Tsao, Ming S.
    Eisenhauer, Elizabeth
    Bradbury, Penelope
    BREAST CANCER RESEARCH, 2017, 19
  • [45] Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling
    Miraoui, Hichem
    Oudina, Karim
    Petite, Herve
    Tanimoto, Yukiho
    Moriyama, Keiji
    Marie, Pierre J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (08) : 4897 - 4904
  • [46] Protease-activated receptor-2 induces expression of vascular endothelial growth factor and cyclooxygenase-2 via the mitogen-activated protein kinase pathway in gastric cancer cells
    Zhang, Cheng
    Gao, Guang-Rong
    Lv, Chen-Guang
    Zhang, Boa-Lei
    Zhang, Zhi-Li
    Zhang, Xue-Feng
    ONCOLOGY REPORTS, 2012, 28 (05) : 1917 - 1923
  • [47] Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1
    Sanabria-Figueroa, Eduardo
    Donnelly, Siobhan M.
    Foy, Kevin C.
    Buss, Meghan C.
    Castellino, Robert C.
    Paplomata, Elisavet
    Taliaferro-Smith, Latonia
    Kaumaya, Pravin T. P.
    Nahta, Rita
    MOLECULAR PHARMACOLOGY, 2015, 87 (02) : 150 - 161
  • [48] Silencing of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs Stimulates Hyperplastic Phenotypes through Activation of Epidermal Growth Factor Receptor and Hypoxia-Inducible Factor-2α
    Lee, You Mie
    Lee, Sun-Hee
    Lee, Kheun Byeol
    Minh Phuong Nguyen
    Lee, Min-Young
    Park, Gyu Hwan
    Kwon, Mi Jeong
    PLOS ONE, 2013, 8 (12):
  • [49] Mechanism of Rapid Nuclear Factor-E2-Related Factor 2 (Nrf2) Activation via Membrane-Associated Estrogen Receptors: Roles of NADPH Oxidase 1, Neutral Sphingomyelinase 2 and Epidermal Growth Factor Receptor (EGFR)
    Ishii, Tetsuro
    Warabi, Eiji
    ANTIOXIDANTS, 2019, 8 (03)
  • [50] Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib
    Leow, Ching Ching
    Chesebrough, Jon
    Coffman, Karen T.
    Fazenbaker, Christine A.
    Gooya, John
    Weng, David
    Coats, Steve
    Jackson, Dowdy
    Jallal, Bahija
    Chang, Yong
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) : 2131 - 2141